Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

Iterum Therapeutics plc (ITRM) Class Action Lawsuit (August 2021)

Closed

1:21cv4181 • August 5, 2021

Class Period Start

November 30, 2020

Class Period End

July 26, 2021

PSLRA Deadline

October 4, 2021

Case Allegations

10b5

Statutes of Repose

Nov 30, 2023

Country

United States

Court

Federal Court

Docket History

Jan 27, 2023

No Appeal- Closed

Dec 28, 2022

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Apr 8, 2022

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jan 26, 2022

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Iterum Therapeutics plc. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Nov 15, 2021

Scheduling Order

View all Updates

TOP